<p>Doximity, Inc.（纽约证券交易所代码：DOCS - 获取免费报告）的股票在目前覆盖该公司的五家券商中获得了 “买入” 的平均评级，Marketbeat.com 报道。两位投资分析师给予该股票持有评级，一位给予买入评级，另外两位则给予强烈买入评级。</p>
<ul>
<li>目前值得购买的 100 美元以下最佳股票</li>
</ul>
<p>最近，一些券商对 DOCS 进行了评估。华尔街 Zen 在周六的研究报告中将 Doximity 的评级从 “买入” 下调至 “持有”。Weiss Ratings 在 12 月 24 日的研究报告中重申了对 Doximity 股票的 “持有（c+）” 评级。加拿大皇家银行在周四的研究报告中将 Doximity 的评级上调至 “适度买入”。巴克莱在 12 月 8 日的研究报告中将 Doximity 的评级上调至 “强烈买入”。最后，Truist Financial 在周四的报告中将 Doximity 的评级从 “持有” 上调至 “强烈买入”。</p>
<p><strong>阅读我们关于 DOCS 的最新报告</strong></p>
<h2>Doximity 新闻汇总</h2>
<ul>
<li>2 个具有爆炸性潜力的新 IPO</li>
</ul>
<p>以下是本周影响 Doximity 的主要新闻：</p>
<ul>
<li>积极情绪：Truist 将 DOCS 的评级从 “持有” 上调至 “强烈买入”，表明对短期上涨和产品/市场势头的信心，这可能支持股票的反弹。Truist 升级</li>
<li>积极情绪：加拿大皇家银行（RBC）将 DOCS 的评级调整为 “适度买入”，称其具有持久的增长护城河——这增强了长期增长的论点，并可能吸引那些希望超越近期波动的买家。RBC 覆盖</li>
<li>积极情绪：高盛将 DOCS 的评级从 “强烈卖出” 上调至 “持有”——这一举动降低了来自主要机构的下行风险，尽管高盛警告估值重置；这一变化可以消除与之前非常负面评级相关的卖压。高盛升级</li>
<li>中性情绪：覆盖报告评估 DOCS 与同行的比较，并提供对定位的关键审查——对投资者有用的背景，但本身并不是立即的催化剂。竞争对手评估</li>
<li>中性情绪：雅虎财经在波动交易后审查估值，并讨论最近的 AI 产品更新；产品发展是积极的，但估值和波动性使短期前景复杂。估值与 AI 更新</li>
<li>消极情绪：华尔街 Zen 将 DOCS 的评级下调至 “持有”，这可能在投资者中增加卖压，导致对新下调的反应并加剧短期谨慎。华尔街 Zen 下调</li>
</ul>
<h2>Doximity 股票表现</h2>
<p>纽约证券交易所 DOCS 周五开盘价为 43.85 美元。该公司的市值为 82.6 亿美元，市盈率为 34.80，市盈增长比率为 2.03，贝塔值为 1.39。Doximity 的年低点为 43.21 美元，年高点为 85.21 美元。</p>
<h2>关于 Doximity</h2>
<p>（获取免费报告）</p>
<p>Doximity 以 DOCS 的名义运营一个数字专业网络和通信平台，主要为临床医生设计。公司总部位于旧金山，连接医生、护士执业者、医师助理和其他医疗专业人员，提供简化临床沟通、远程医疗交付和获取专业特定医疗信息的工具。其平台被定位为一个专业中心，临床医生可以在此管理工作流程、跟进医学新闻并与同行安全协作。</p>
<p>该公司的产品包括安全消息传递和视频远程医疗功能，使临床医生能够在保护患者信息的同时与患者和同事进行咨询。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票超过 Doximity</li>
<li>为什么特朗普和马斯克突然关心福特诺克斯</li>
<li>请勿删除，立即阅读</li>
<li>家族信托如何帮助保护您的财富</li>
<li>明天买这只股票？</li>
<li>领取您 5.39 亿美元 AI 股权支票的份额</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1000 美元在 Doximity 吗？</h2>
<p>在您考虑 Doximity 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Doximity 并不在名单上。</p>
<p>虽然 Doximity 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

DOCS

<p>Doximity, Inc.（纽约证券交易所代码：DOCS）获得了五家券商的平均评级为 “买入”，其中包括两项持有评级、一项买入评级和两项强烈买入评级。最近的分析师行动包括 Truist Financial 和加拿大皇家银行的升级，而华尔街 Zen 则将该股票下调至持有。Doximity 运营着一个为医疗专业人士提供的数字网络，促进沟通和远程医疗服务。该股票开盘价为 43.85 美元，市值为 82.6 亿美元，市盈率为 34.80</p>

<p>Shares of Doximity, Inc. (NYSE:DOCS - Get Free Report) have received an average rating of &#34;Buy&#34; from the five brokerages that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company.</p>
<div class="lb-trans"><p>Doximity, Inc.（纽约证券交易所代码：DOCS - 获取免费报告）的股票在目前覆盖该公司的五家券商中获得了 “买入” 的平均评级，Marketbeat.com 报道。两位投资分析师给予该股票持有评级，一位给予买入评级，另外两位则给予强烈买入评级。</p>
</div><ul>
<li>The Best Stocks Under $100 to Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>目前值得购买的 100 美元以下最佳股票</li>
</ul>
</div><p>A number of brokerages recently weighed in on DOCS. Wall Street Zen lowered Doximity from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday. Weiss Ratings restated a &#34;hold (c+)&#34; rating on shares of Doximity in a research report on Wednesday, December 24th. Royal Bank Of Canada raised shares of Doximity to a &#34;moderate buy&#34; rating in a research note on Thursday. Barclays raised shares of Doximity to a &#34;strong-buy&#34; rating in a research note on Monday, December 8th. Finally, Truist Financial upgraded shares of Doximity from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Thursday.</p>
<div class="lb-trans"><p>最近，一些券商对 DOCS 进行了评估。华尔街 Zen 在周六的研究报告中将 Doximity 的评级从 “买入” 下调至 “持有”。Weiss Ratings 在 12 月 24 日的研究报告中重申了对 Doximity 股票的 “持有（c+）” 评级。加拿大皇家银行在周四的研究报告中将 Doximity 的评级上调至 “适度买入”。巴克莱在 12 月 8 日的研究报告中将 Doximity 的评级上调至 “强烈买入”。最后，Truist Financial 在周四的报告中将 Doximity 的评级从 “持有” 上调至 “强烈买入”。</p>
</div><p><strong>Read Our Latest Report on DOCS</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 DOCS 的最新报告</strong></p>
</div><h2>Doximity News Roundup</h2>
<div class="lb-trans"><h2>Doximity 新闻汇总</h2>
</div><ul>
<li>2 New IPOs with Explosive Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>2 个具有爆炸性潜力的新 IPO</li>
</ul>
</div><p>Here are the key news stories impacting Doximity this week:</p>
<div class="lb-trans"><p>以下是本周影响 Doximity 的主要新闻：</p>
</div><ul>
<li>Positive Sentiment: Truist upgraded DOCS from &#34;hold&#34; to &#34;strong-buy,&#34; signaling conviction in near-term upside and product/market momentum that could support a rebound in shares. Truist Upgrade</li>
<li>Positive Sentiment: Royal Bank of Canada (RBC) moved DOCS to a &#34;moderate buy,&#34; citing a durable growth moat—this bolsters the long-term growth thesis and may attract buyers looking past recent volatility. RBC Coverage</li>
<li>Positive Sentiment: Goldman Sachs upgraded DOCS from &#34;strong sell&#34; to &#34;hold&#34; — a move that reduces downside risk from a major house, even as Goldman warns of a valuation reset; the change can remove selling pressure tied to the prior very negative rating. Goldman Upgrade</li>
<li>Neutral Sentiment: Coverage pieces assess DOCS vs. peers and provide a critical review of positioning—useful context for investors but not an immediate catalyst by themselves. Competitor Review</li>
<li>Neutral Sentiment: Yahoo Finance examines valuation after volatile trading and discusses recent AI product updates; product developments are positive, but valuation and volatility keep the near-term outlook mixed. Valuation &amp; AI Update</li>
<li>Negative Sentiment: Wall Street Zen lowered DOCS to a &#34;hold,&#34; which could add selling pressure among investors who react to fresh downgrades and heighten short-term caution. Wall Street Zen Downgrade</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：Truist 将 DOCS 的评级从 “持有” 上调至 “强烈买入”，表明对短期上涨和产品/市场势头的信心，这可能支持股票的反弹。Truist 升级</li>
<li>积极情绪：加拿大皇家银行（RBC）将 DOCS 的评级调整为 “适度买入”，称其具有持久的增长护城河——这增强了长期增长的论点，并可能吸引那些希望超越近期波动的买家。RBC 覆盖</li>
<li>积极情绪：高盛将 DOCS 的评级从 “强烈卖出” 上调至 “持有”——这一举动降低了来自主要机构的下行风险，尽管高盛警告估值重置；这一变化可以消除与之前非常负面评级相关的卖压。高盛升级</li>
<li>中性情绪：覆盖报告评估 DOCS 与同行的比较，并提供对定位的关键审查——对投资者有用的背景，但本身并不是立即的催化剂。竞争对手评估</li>
<li>中性情绪：雅虎财经在波动交易后审查估值，并讨论最近的 AI 产品更新；产品发展是积极的，但估值和波动性使短期前景复杂。估值与 AI 更新</li>
<li>消极情绪：华尔街 Zen 将 DOCS 的评级下调至 “持有”，这可能在投资者中增加卖压，导致对新下调的反应并加剧短期谨慎。华尔街 Zen 下调</li>
</ul>
</div><h2>Doximity Stock Performance</h2>
<div class="lb-trans"><h2>Doximity 股票表现</h2>
</div><p>NYSE DOCS opened at $43.85 on Friday. The company has a market cap of $8.26 billion, a P/E ratio of 34.80, a price-to-earnings-growth ratio of 2.03 and a beta of 1.39. Doximity has a one year low of $43.21 and a one year high of $85.21.</p>
<div class="lb-trans"><p>纽约证券交易所 DOCS 周五开盘价为 43.85 美元。该公司的市值为 82.6 亿美元，市盈率为 34.80，市盈增长比率为 2.03，贝塔值为 1.39。Doximity 的年低点为 43.21 美元，年高点为 85.21 美元。</p>
</div><h2>About Doximity</h2>
<div class="lb-trans"><h2>关于 Doximity</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.</p>
<div class="lb-trans"><p>Doximity 以 DOCS 的名义运营一个数字专业网络和通信平台，主要为临床医生设计。公司总部位于旧金山，连接医生、护士执业者、医师助理和其他医疗专业人员，提供简化临床沟通、远程医疗交付和获取专业特定医疗信息的工具。其平台被定位为一个专业中心，临床医生可以在此管理工作流程、跟进医学新闻并与同行安全协作。</p>
</div><p>The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.</p>
<div class="lb-trans"><p>该公司的产品包括安全消息传递和视频远程医疗功能，使临床医生能够在保护患者信息的同时与患者和同事进行咨询。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Doximity</li>
<li>Why Trump and Musk suddenly care about Fort Knox</li>
<li>Do not delete, read immediately</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Buy this stock tomorrow?</li>
<li>Claim Your Share of $5.39 BILLION in AI Equity Checks</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Doximity</li>
<li>为什么特朗普和马斯克突然关心福特诺克斯</li>
<li>请勿删除，立即阅读</li>
<li>家族信托如何帮助保护您的财富</li>
<li>明天买这只股票？</li>
<li>领取您 5.39 亿美元 AI 股权支票的份额</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=DOCS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Doximity Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1000 美元在 Doximity 吗？</h2>
</div><p>Before you consider Doximity, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Doximity 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Doximity 并不在名单上。</p>
</div><p>While Doximity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Doximity 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Doximity, Inc. (NYSE:DOCS) 被分析师一致评为 “买入” 评级